Form 4: ORTHOPEDIATRICS Director Marie Infante Acquires 8,401 Shares of Common Stock
Insider Transaction Report
ORTHOPEDIATRICS Corp. Director Marie C. Infante (Reynolds) reported the acquisition of 8,401 shares of common stock on May 23, 2025, increasing her total beneficial ownership to 19,766 shares.
Summary
- Director Marie C. Infante (Reynolds) acquired 8,401 shares of ORTHOPEDIATRICS CORP (KIDS) common stock.
- The transaction occurred on May 23, 2025.
- The acquisition price was $0 per share, indicating a grant or award rather than a cash purchase.
- Following this transaction, Ms. Infante beneficially owns a total of 19,766 shares of common stock.
- This total beneficial ownership includes 10,900 shares of restricted stock awards.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, even if a grant, generally indicates alignment of interests and confidence in the company's future, which is a positive signal. No negative information is present in this filing.
Positives
- An insider, Director Marie C. Infante, increased her beneficial ownership in the company by acquiring 8,401 shares, which can signal confidence in the company's future.
- The acquisition at a $0 price suggests a stock grant or award, a common form of compensation for directors that aligns their interests with those of shareholders.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. However, director stock grants are a common practice in the medical device or orthopedics industry to align executive interests with shareholder value.
Stakeholder Impact
- Shareholders: The increase in director ownership may be viewed positively as it aligns management's interests with shareholder value.
- Employees: No direct impact on employees is indicated by this filing.
- Customers: No direct impact on customers is indicated by this filing.
- Suppliers: No direct impact on suppliers is indicated by this filing.
- Creditors: No direct impact on creditors is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 05/23/2025 | Date of transaction where Director Marie C. Infante acquired 8,401 shares of common stock. |
| 05/28/2025 | Date the Form 4 was signed by the Attorney-in-Fact for the Reporting Person. |
Keywords
ORTHOPEDIATRICS CORP, KIDS, Form 4, Insider Transaction, Beneficial Ownership, Director Stock Acquisition, Restricted Stock Award, Marie C. Infante
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.